Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105017158B reveals a novel synthesis route for cis-Rosuvastatin calcium impurities, offering high purity and scalable production for global supply chains.
Patent CN106749445A reveals a stable, high-yield synthesis for epirubicin intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN120795037B details novel ruthenium compounds with superior antibacterial activity. Discover cost-effective synthesis and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN101619037A reveals a streamlined route for polyphenyl pyridinium salts. Discover cost-effective manufacturing and high-purity supply chain solutions for advanced materials.
Novel nitro-reduction route avoids column chromatography, ensuring high purity and yield for scalable API manufacturing.
Patent CN104093718B reveals a solvent-free Cu-catalyzed process enabling high-purity pharmaceutical intermediates with significant cost reduction and supply chain reliability.
Patent CN108299272B details a high-yield AlCl3-catalyzed route for fluorinated ketones, offering cost reduction and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN107216326A reveals novel tandem catalysis for phenanthridine derivatives. Enables cost reduction and scalable supply for high-purity pharmaceutical intermediates manufacturing.
Novel thiourea-catalyzed asymmetric synthesis of trifluoromethyl bisoxazoles with high ee. Ideal for anticancer drug development and cost-effective API manufacturing.
Patent CN105523874A reveals a mild catalytic method for 2,2-dihalo-1,3-dicarbonyl derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Ru/Ni dual-catalyzed method for cyano-enamines offers mild conditions and high selectivity, optimizing pharmaceutical intermediate supply chains.
Patent CN111995636A details a novel Ru-catalyzed hydrosilylation route for ortho-hydroxy-nitrogen silanes, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN113735926A reveals a high-yield diazotization route for uridine production, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN102276537A details a streamlined 4-step synthesis for 2-cyano-5-aminopyrimidine. Discover cost-effective manufacturing and scalable supply chain solutions for this critical heterocyclic building block.
Patent CN112321535B reveals a novel ketone-based route for Imaric Acid, offering high purity and cost reduction for Imatinib manufacturing supply chains.
Novel four-step synthesis of PARP1 inhibitor intermediate via nitration and oxidative deamination. Offers high purity and scalable route for pharmaceutical manufacturing.
Patent CN102241614B details a phosphotungstic acid catalyzed method for N-alkyl amides offering significant supply chain stability and cost reduction advantages.
Patent CN106995373B reveals a one-pot synthesis method using ammonium iodide. This breakthrough offers significant supply chain stability and cost reduction advantages.
Patent CN113185419B reveals a greener 4-step route for oxybuprocaine hydrochloride, eliminating genotoxic risks and enabling cost-effective commercial scale-up.
Patent CN114853797B reveals a mild selenium-catalyzed method for alpha-amino boron compounds, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.